Fred Aslan, M.D. Vice President Office: Palo Alto Email Fred Education B.S., Biology, Duke University M.B.A., Harvard Business School (with Distinction) M.D., Yale University School of Medicine

Fred joined Venrock in 2006 and is focused on healthcare. Prior to Venrock, he was with Atlas Venture assessing investments in medical devices and biotechnology.  Earlier in his career, Fred was Director of Business Development and Head of Investor Relations for CuraGen Corporation, an oncology-focused drug development company.  In this role, he was responsible for strategic planning, the in-licensing of a clinical stage oncology product, securing sell-side analyst coverage and helping raise over $100 million. Prior to CuraGen, he worked at Boston Consulting Group where he advised biotechnology and pharmaceutical companies.  Fred’s medical background combined with his business experience brings practical insights and advice to any healthcare entrepreneur.

“We look to work with entrepreneurs and scientists who are developing technology breakthroughs that will shape the future of medicine and improve the quality of patient care. Developing innovative technologies in healthcare takes time, and we pride ourselves in being true partners, working side-by-side with our entrepreneurs to help them build their companies into successful enterprises.”